This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is to find out if the drug metformin (Gloucophage XR, Bristol -Myers Squibb Co. Inc) will help obese, non-diabetic adolescents lose weight . We will find this out by comparing one group of subjects that will take metformin to another group who will not take the drug.
No Sub Projects information available for 5M01RR002172-24 6216
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5M01RR002172-24 6216
Patents
No Patents information available for 5M01RR002172-24 6216
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5M01RR002172-24 6216
Clinical Studies
No Clinical Studies information available for 5M01RR002172-24 6216
News and More
Related News Releases
No news release information available for 5M01RR002172-24 6216
History
No Historical information available for 5M01RR002172-24 6216
Similar Projects
No Similar Projects information available for 5M01RR002172-24 6216